Lovastatin Inhibits G1/S Transition of Normal Human B-Lymphocytes Independent of Apoptosis
- 10 October 1999
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 252 (1), 144-153
- https://doi.org/10.1006/excr.1999.4608
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Geranylgeraniol potentiates lovastatin inhibition of oncogenic H-Ras processing and signaling while preventing cytotoxicityOncogene, 1997
- Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in FibroblastsPublished by Elsevier BV ,1996
- E2F and Cell Proliferation: A World Turned Upside DownCell, 1996
- Lovastatin Inhibits Proliferation and Differentiation and Causes Apoptosis in Lipopolysaccharide-Stimulated Murine B CellsBiochemical and Biophysical Research Communications, 1995
- Co-capping of ras proteins with surface immunoglobulins in B lymphocytesNature, 1990
- Small G proteins are expressed ubiquitously in lymphoid cells and do not correspond to Bcl-2Nature, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Functional properties of CD19 B lymphocytes positively selected from buffy coats by immunomagnetic separationEuropean Journal of Immunology, 1989
- G protein regulation of receptor signallingImmunology Today, 1988
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970